Single-dose oral cholera vaccine completes phase 1 trial with promising results

A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in a phase 1 clinical trial, with results published in The Lancet Infectious Diseases.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup